SCHEMBL12435541

SCHEMBL12435541

C#CC(S)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.47
▸ CYP1A2 P05177 3/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ EPHX1 P07099 1/20 0.44
▸ ANPEP P15144 1/20 0.43
▸ MAOA P21397 5/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ SNCA P37840 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ SLC6A2 P23975 2/20 0.41
▸ TAAR1 Q96RJ0 2/20 0.41
▸ SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7512121 0.77 CYP1A2 (0.45) CYP1A2EPHX1ANPEPMAOAPKM
SCHEMBL10940258 0.77 EPHX1 (0.44) MAOBCYP1A2EPHX1ANPEPMAOA
SCHEMBL28422388 0.74 TAAR1 (0.43) CYP1A2CYP2D6TSHRCYP3A4EPHX1
SCHEMBL2748352 0.73 MAOB (0.56) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL9793910 0.73 MAOB (0.47) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL28010555 0.73 MAOB (0.47) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL4950698 0.73 EPHX1 (0.56) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL134502 0.73 MAOB (0.47) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL4730309 0.73 EPHX1 (0.56) MAOBCYP1A2CYP2D6TSHRCYP3A4
SCHEMBL4650877 0.72 EPHX1 (0.55) CYP1A2CYP2D6EPHX1ANPEPMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094708-A2 SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATIING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS DANA-FARBER CANCER INSTITUTE, INC (US) 2011-08-04 — — WO disclosed
Send feedback